Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-10-07FDA Approved: COMBIVENT RESPIMAT — Original Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved Combivent Respimat (ipratropium bromide and albuterol) in an original application for relief of bronchospasm associated with ch…
-
FDA approval · 2011-08-18FDA Approved: DULERA — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for DULERA (mometasone furoate/formoterol fumarate dihydrate) submitted by Organon LLC.
-
FDA approval · 2011-08-18FDA Approved: BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for Budesonide and Formoterol Fumarate Dihydrate (Symbicort) from AstraZeneca.
-
FDA approval · 2011-07-28FDA Approved: SPIRIVA HANDIHALER — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for Spiriva HandiHaler (tiotropium bromide) from Boehringer Ingelheim Pharmaceuticals, Inc. This act…
-
FDA approval · 2011-06-27FDA Approved: ADVAIR HFA — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Advair HFA (fluticasone propionate and salmeterol xinafoate) submitted by GlaxoSmithKline LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-06-27FDA Approved: ADVAIR DISKUS — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Advair Diskus (fluticasone propionate and salmeterol) submitted by GlaxoSmithKline LLC.
-
FDA approval · 2011-06-27FDA Approved: SEREVENT DISKUS — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for SEREVENT DISKUS (salmeterol xinafoate) filed by GlaxoSmithKline LLC. This action updates the…
-
FDA approval · 2011-05-10FDA Approved: ADVAIR HFA — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for ADVAIR HFA (fluticasone propionate and salmeterol xinafoate) submitted by GlaxoSmithKline LLC.
-
FDA approval · 2011-05-10FDA Approved: ADVAIR DISKUS — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental NDA for Advair Diskus (fluticasone propionate and salmeterol) submitted by GlaxoSmithKline LLC. The approval ind…
-
FDA approval · 2011-05-10FDA Approved: IPRATROPIUM BROMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for ipratropium bromide by Hikma Pharmaceuticals USA Inc. under ANDA 076664, updating an already…
-
FDA approval · 2011-04-13FDA Approved: THEOPHYLLINE — Original Application (Chartwell RX, LLC)
FDA approved Chartwell RX, LLC's original application for Theophylline as a generic drug. The approval indicates authorization for a generic…
-
FDA approval · 2011-04-08FDA Approved: TERBUTALINE SULFATE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for Terbutaline Sulfate from Amneal Pharmaceuticals of New York LLC, authorizing a modification to a…
-
FDA approval · 2011-02-28FDA Approved: DALIRESP — Original Application (AstraZeneca Pharmaceuticals LP)
FDA approved the original application for Daliresp (roflumilast), a PDE-4 inhibitor, to reduce the risk of COPD exacerbations in patients wi…
-
FDA approval · 2011-02-16FDA Approved: BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for budesonide and formoterol fumarate dihydrate (Symbicort) from AstraZeneca Pharmaceuticals LP.
-
FDA approval · 2011-02-01FDA Approved: FORMOTEROL FUMARATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Formoterol Fumarate submitted by Mylan Pharmaceuticals, resulting in a change to the product…
-
FDA approval · 2011-01-04FDA Approved: ADVAIR HFA — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for ADVAIR HFA submitted by GlaxoSmithKline LLC.
-
FDA approval · 2011-01-04FDA Approved: ADVAIR DISKUS — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for Advair Diskus submitted by GlaxoSmithKline LLC.
-
FDA approval · 2010-12-30FDA Approved: SEREVENT DISKUS — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for SEREVENT DISKUS (salmeterol xinafoate) submitted by GlaxoSmithKline LLC.
-
FDA approval · 2010-12-23FDA Approved: ATROVENT HFA — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for Atrovent HFA (ipratropium bromide) from Boehringer Ingelheim Pharmaceuticals, Inc.
-
FDA approval · 2010-12-10FDA Approved: ALBUTEROL SULFATE HFA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for Albuterol Sulfate HFA inhalation aerosol.
-
FDA approval · 2010-12-08FDA Approved: ALBUTEROL SULFATE HFA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for ALBUTEROL SULFATE HFA submitted by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2010-11-18FDA Approved: SEREVENT DISKUS — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for SEREVENT DISKUS (salmeterol xinafoate) submitted by GlaxoSmithKline LLC.
-
FDA approval · 2010-10-27FDA Approved: THEOPHYLLINE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's Theophylline as an Original Application (ANDA) product, making it a generic version of theoph…
-
FDA approval · 2010-08-17FDA Approved: ALBUTEROL SULFATE HFA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Albuterol Sulfate HFA submitted by Teva Pharmaceuticals USA, Inc., potentially updating labeling…
-
FDA approval · 2010-07-13FDA Approved: THEOPHYLLINE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's Theophylline from an Original Application; Theophylline is a bronchodilator used to treat symptoms of obstructive ai…